Skip to main content
. 2021 Feb 4;20:410–421. doi: 10.1016/j.omto.2021.02.001

Figure 5.

Figure 5

Predicting the response to immune checkpoint blockade therapy and revealed diverse overall survival outcomes in the three immunophenotypes

(A) Prediction results of the response to anti-PD-L1 therapy. (B) Prediction results of the response to anti-CTAL-4 and anti-PD-1 therapy. (C) Different overall survival outcomes in the three immunophenotypes.